An overview of the initial experience with AK-2123 as a hypoxic cell sensitizer with radiation in the treatment of advanced head and neck cancers

International Journal of Radiation Oncology Biology Physics

Volumn 34, Issue 5, 1996, Pages 1121-1124

  Huilgol, Nagraj G ^a   Chatterjee, Neela ^a   Mehta, Ashok R ^a  

^a DR BALABHAI NANAVATI HOSPITAL   (India)

Author keywords

AK 2123; Discontinuous accelerated hyperfractionated radiation; Head and neck cancers; Hypoxic cell sensitizer

Indexed keywords

RADIOSENSITIZING AGENT; SENAZOLE; TRIAZOLE DERIVATIVE;

ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HEAD AND NECK CANCER; HUMAN; HYPOXIC CELL; INTRAVENOUS DRUG ADMINISTRATION; OROPHARYNX CANCER; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOSENSITIZATION;

EID: 0029870717     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(95)02181-7     Document Type: Article

References (7)

1. Chaplin, D. J.; Durand, R. E.; Olive P. L. Acute hypoxia in tumour: Implications for modifiers of radiation effects. Int. J. Radiat. Oncol. Biol. Phys. 12:1279-1292; 1986.
2. Huilgol, N. G.; Savithri, S.; Mehta, A. R. Discontinuous accelerated fractionation in the treatment of advanced head and neck neoplasms - A preliminary report. Acta Oncol. 32(1)1:84; 1993.
3. Kagiya, V. T. Communication of ICRP on CMCRT: 1. AK-2123 Radiosensit. Newslett. 9(3):1; July 1990.
4. Lee, D. J.; Pajak, T.; Mareial, V. A.; Rotman, M.; Cooper, J. S.; Ortiz, H. G.; Beitler, J. J.; Abrams, R. A.; Curran, W. J.; Coleman, C. N.; Wasserman, T. H. Results of an RTOG Phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole (SR-2508) with radiotherapy alone for locally advanced head and neck carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 30(Suppl. 1):#102; 1994.
5. Overgaard, J.; Sand, H. H.; Jorgensen, K. Hansen, M. H. Primary radiotherapy of larynx and pharynx carcinoma - An analysis of some factors influencing local control and survival. Int. J. Radiat. Oncol. Biol. Phys. 12:515-521; 1986.
6. Overgaard, J.; Sand, H. H.; Anderson, A. P.; Misonidazole as an adjuvant to radiotherapy in the treatment of invasive carcinoma of the larynx and pharynx: 2nd interim analysis of the Danish Head and Neck cancer study. Conference on Chemical Modifiers of Cancer Treatment, Clearwater, FL, 1985:1-23.
7. Vaupel, P.; Kallinowski, F.; Okinieff, P. Blood flow, oxygen and nutrient supply and metabolic environment of human tumours. A review. Cancer Res. 49:6449-6465; 1989.